vs

Side-by-side financial comparison of AVINO SILVER & GOLD MINES LTD (ASM) and NEKTAR THERAPEUTICS (NKTR). Click either name above to swap in a different company.

NEKTAR THERAPEUTICS is the larger business by last-quarter revenue ($21.8M vs $21.0M, roughly 1.0× AVINO SILVER & GOLD MINES LTD). AVINO SILVER & GOLD MINES LTD runs the higher net margin — 36.6% vs -165.4%, a 202.0% gap on every dollar of revenue. On growth, AVINO SILVER & GOLD MINES LTD posted the faster year-over-year revenue change (44.0% vs -25.3%). Over the past eight quarters, AVINO SILVER & GOLD MINES LTD's revenue compounded faster (51.1% CAGR vs 0.4%).

Avino Silver & Gold Mines Ltd is a Canada-based mining company engaged in the exploration, development, and production of precious and base metals, primarily silver, gold, and copper. It operates its flagship Avino Mine property in Durango, Mexico, with its metal products supplied to global industrial and commodity markets.

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

ASM vs NKTR — Head-to-Head

Bigger by revenue
NKTR
NKTR
1.0× larger
NKTR
$21.8M
$21.0M
ASM
Growing faster (revenue YoY)
ASM
ASM
+69.2% gap
ASM
44.0%
-25.3%
NKTR
Higher net margin
ASM
ASM
202.0% more per $
ASM
36.6%
-165.4%
NKTR
Faster 2-yr revenue CAGR
ASM
ASM
Annualised
ASM
51.1%
0.4%
NKTR

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
ASM
ASM
NKTR
NKTR
Revenue
$21.0M
$21.8M
Net Profit
$7.7M
$-36.1M
Gross Margin
47.1%
Operating Margin
-126.9%
Net Margin
36.6%
-165.4%
Revenue YoY
44.0%
-25.3%
Net Profit YoY
558.9%
-596.9%
EPS (diluted)
$0.05
$-4.67

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ASM
ASM
NKTR
NKTR
Q4 25
$21.8M
Q3 25
$21.0M
$11.8M
Q2 25
$21.8M
$11.2M
Q1 25
$18.8M
$10.5M
Q4 24
$29.2M
Q3 24
$14.6M
$24.1M
Q2 24
$14.8M
$23.5M
Q1 24
$12.4M
$21.6M
Net Profit
ASM
ASM
NKTR
NKTR
Q4 25
$-36.1M
Q3 25
$7.7M
$-35.5M
Q2 25
$2.9M
$-41.6M
Q1 25
$5.6M
$-50.9M
Q4 24
$7.3M
Q3 24
$1.2M
$-37.1M
Q2 24
$1.2M
$-52.4M
Q1 24
$599.0K
$-36.8M
Gross Margin
ASM
ASM
NKTR
NKTR
Q4 25
Q3 25
47.1%
Q2 25
46.9%
Q1 25
56.1%
Q4 24
72.7%
Q3 24
39.1%
81.6%
Q2 24
31.8%
58.5%
Q1 24
18.9%
60.6%
Operating Margin
ASM
ASM
NKTR
NKTR
Q4 25
-126.9%
Q3 25
-268.6%
Q2 25
-324.2%
Q1 25
-425.8%
Q4 24
49.2%
Q3 24
-142.4%
Q2 24
-211.9%
Q1 24
-163.7%
Net Margin
ASM
ASM
NKTR
NKTR
Q4 25
-165.4%
Q3 25
36.6%
-301.3%
Q2 25
13.1%
-372.2%
Q1 25
29.8%
-486.4%
Q4 24
24.9%
Q3 24
8.0%
-153.6%
Q2 24
8.4%
-222.9%
Q1 24
4.8%
-170.1%
EPS (diluted)
ASM
ASM
NKTR
NKTR
Q4 25
$-4.67
Q3 25
$0.05
$-1.87
Q2 25
$0.02
$-2.95
Q1 25
$0.04
$-0.24
Q4 24
$-2.07
Q3 24
$0.01
$-2.66
Q2 24
$0.01
$-3.76
Q1 24
$0.00
$-0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ASM
ASM
NKTR
NKTR
Cash + ST InvestmentsLiquidity on hand
$57.3M
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$182.1M
$89.8M
Total Assets
$221.9M
$280.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ASM
ASM
NKTR
NKTR
Q4 25
$15.1M
Q3 25
$57.3M
$41.0M
Q2 25
$37.3M
$43.0M
Q1 25
$26.6M
$38.9M
Q4 24
$44.3M
Q3 24
$7.8M
$30.1M
Q2 24
$5.3M
$27.9M
Q1 24
$3.5M
$48.6M
Stockholders' Equity
ASM
ASM
NKTR
NKTR
Q4 25
$89.8M
Q3 25
$182.1M
$85.1M
Q2 25
$144.8M
$-24.2M
Q1 25
$132.3M
$13.7M
Q4 24
$60.7M
Q3 24
$114.5M
$48.9M
Q2 24
$112.2M
$79.7M
Q1 24
$107.8M
$126.7M
Total Assets
ASM
ASM
NKTR
NKTR
Q4 25
$280.4M
Q3 25
$221.9M
$301.3M
Q2 25
$174.7M
$207.5M
Q1 25
$157.7M
$256.2M
Q4 24
$303.9M
Q3 24
$135.4M
$308.0M
Q2 24
$133.7M
$343.3M
Q1 24
$128.6M
$396.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ASM
ASM
NKTR
NKTR
Operating Cash FlowLast quarter
$8.3M
$-65.0M
Free Cash FlowOCF − Capex
$-65.0M
FCF MarginFCF / Revenue
-298.0%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
1.08×
TTM Free Cash FlowTrailing 4 quarters
$-208.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ASM
ASM
NKTR
NKTR
Q4 25
$-65.0M
Q3 25
$8.3M
$-48.8M
Q2 25
$8.3M
$-45.7M
Q1 25
$758.0K
$-49.1M
Q4 24
$-46.2M
Q3 24
$4.1M
$-43.9M
Q2 24
$1.1M
$-37.7M
Q1 24
$2.3M
$-47.9M
Free Cash Flow
ASM
ASM
NKTR
NKTR
Q4 25
$-65.0M
Q3 25
$-48.9M
Q2 25
$-45.8M
Q1 25
$-49.1M
Q4 24
$-46.6M
Q3 24
$-44.6M
Q2 24
$-37.9M
Q1 24
$-48.0M
FCF Margin
ASM
ASM
NKTR
NKTR
Q4 25
-298.0%
Q3 25
-414.5%
Q2 25
-409.6%
Q1 25
-469.0%
Q4 24
-159.9%
Q3 24
-184.9%
Q2 24
-161.3%
Q1 24
-222.0%
Capex Intensity
ASM
ASM
NKTR
NKTR
Q4 25
0.1%
Q3 25
1.0%
Q2 25
0.3%
Q1 25
0.0%
Q4 24
1.6%
Q3 24
2.8%
Q2 24
0.8%
Q1 24
0.7%
Cash Conversion
ASM
ASM
NKTR
NKTR
Q4 25
Q3 25
1.08×
Q2 25
2.92×
Q1 25
0.13×
Q4 24
-6.36×
Q3 24
3.55×
Q2 24
0.87×
Q1 24
3.92×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons